PRASCO 326 (Phenylephrine and Guaifenesin SR 25 mg / 900 mg)
Pill with imprint PRASCO 326 is White, Capsule-shape and has been identified as Phenylephrine and Guaifenesin SR 25 mg / 900 mg. It is supplied by Prasco Laboratories.
Guaifenesin/phenylephrine is used in the treatment of sinus symptoms; cough and nasal congestion and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Guaifenesin/phenylephrine 25 mg / 900 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for PRASCO 326
Phenylephrine and Guaifenesin SR
- Imprint:
- PRASCO 326
- Strength:
- 25 mg / 900 mg
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Rx and/or OTC
- Drug Class:
- Upper respiratory combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Prasco Laboratories
- National Drug Code (NDC):
More about guaifenesin / phenylephrine
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- En Español
- 11 Reviews
- Drug class: upper respiratory combinations
- FDA Alerts (1)
Consumer resources
- Guaifenesin and phenylephrine
- Guaifenesin and Phenylephrine Tablets
- Guaifenesin and Phenylephrine Drops
- Guaifenesin and Phenylephrine Liquid
Other brands: Deconex IR, Aldex G, Nariz, Xpect-PE, ... +14 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
